Bologna, Italy

Milena Bachetti

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Milena Bachetti: Innovator in Pharmaceutical Formulations

Introduction

Milena Bachetti is a prominent inventor based in Bologna, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the stabilization of polymorphous forms of rifaximin. With a total of 3 patents to her name, her work has the potential to enhance the efficacy and stability of pharmaceutical products.

Latest Patents

One of her latest patents focuses on the use of polyols to obtain stable polymorphous forms of rifaximin. This invention describes how polyols, which contain at least two hydroxy groups, can be added to rifaximin powder to stabilize the β form. The stability of this polymorph is maintained over time, regardless of environmental humidity. The patent outlines a method for preparing formulations that consist of pure and stable polymorphous forms, which are essential for developing effective pharmaceutical products.

Career Highlights

Throughout her career, Milena has worked with notable companies in the pharmaceutical industry, including Alfa Wassermann S.p.A. and Alfasigma S.p.A. Her expertise in the field has allowed her to contribute to advancements in drug formulation and stability.

Collaborations

Milena has collaborated with esteemed colleagues such as Paola Maffei and Giuseppe Bottoni. These partnerships have further enriched her research and development efforts in the pharmaceutical sector.

Conclusion

Milena Bachetti's innovative work in stabilizing polymorphous forms of rifaximin showcases her dedication to improving pharmaceutical formulations. Her contributions are vital for the advancement of effective and stable drug products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…